Compugen Q2 EPS $(0.11) Beats $(0.13) Estimate
Portfolio Pulse from Benzinga Newsdesk
Compugen (NASDAQ:CGEN) reported Q2 losses of $(0.11) per share, beating the analyst consensus estimate of $(0.13) by 15.38 percent. This is unchanged from the same period last year.
August 07, 2023 | 11:00 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Compugen's Q2 earnings beat analyst estimates by 15.38%, with losses per share of $(0.11). This is consistent with the performance from the same period last year.
Compugen's Q2 earnings beat analyst estimates, which is generally seen as a positive sign by investors. This could lead to an increase in the stock price in the short term. The fact that the performance is consistent with the same period last year suggests stability in the company's financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100